Effective December 9, 2021, Jason Dinges, resigned from the Board of Directors of Kezar Life Sciences, Inc. and from his position as a member of the Nominating and Corporate Governance Committee of the Board. Mr. Dinges’ resignation was not because of a disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Effective December 9, 2021, the Board appointed Courtney Wallace to the Board as a Class I Director, to serve until the Company’s 2022 annual meeting of stockholders and until her successor is duly elected and qualified, or her earlier resignation or removal.